Paris, France – In a breakthrough for millions seeking a sleep apnea solution without CPAP, Back2Sleep, a European medical device company, announces a 92% user satisfaction rate for its innovative nasal stent. The CE-certified device offers a non-invasive, travel-friendly alternative to bulky CPAP machines and jaw-repositioning devices.
With over 1 million units distributed globally and availability through 57,000 pharmacies, Back2Sleep is quickly becoming the go-to choice for those who want better sleep without compromising comfort or mobility.
Addressing a Global Sleep Health Challenge
An estimated 22 million Americans and 175 million Europeans suffer from sleep apnea, with 80% remaining undiagnosed. For many, traditional CPAP machines present barriers including discomfort, high cost, and dependency on electricity.
Back2Sleep’s nasal stent provides a simpler path. Designed to maintain nasal airway patency, the soft silicone stent is inserted in just 10 seconds and silently works throughout the night—no straps, no masks, and no noise.
Clinical-Backed User Satisfaction
Key user-reported results:
- 92% satisfaction rate among surveyed users
- Noticeable sleep comfort improvement within the first week
- High retention and repeat use compared to CPAP and MADs
- Portable, discreet, and easy to use
- Skin-tested, medical-grade materials with multiple sizing options
According to a 2024 peer-reviewed clinical trial published in the European Respiratory Journal, Back2Sleep demonstrated a 64% reduction in AHI (apnea-hypopnea index) and 96%+ oxygen saturation maintenance over six months of use.
Innovation Born from ENT Expertise
Backed by 10 years of research and development under the guidance of ENT specialist Prof. Frédéric Chabolle, the device is engineered for people who cannot tolerate CPAP or are looking for a pre-surgical alternative.
“Back2Sleep offers a direct, comfortable solution to airway obstruction during sleep,” said Professor Chabolle. “It’s discreet, effective, and widely appreciated by patients.”
Business & Market Highlights
- 1+ million tubes sold across Europe, North America, and Asia
- Partnerships with 57,000+ pharmacies
- Competitive pricing: Starter Kit from €39, monthly cost from €0.83/night
- Subscription and size options available
As global demand grows for simple, effective, and portable sleep solutions, Back2Sleep positions itself as a leader in sleep comfort innovation.
About Back2Sleep
Back2Sleep is a European medical device company focused on innovative treatments for snoring and sleep apnea. Its CE-certified nasal stent is the result of a decade of clinical research and ENT expertise. The device is not intended to diagnose or treat sleep disorders. Users should consult a healthcare professional if sleep apnea is suspected.
Contact Info:
Name: Back2Sleep
Email: Send Email
Organization: Back2Sleep
Website: https://back2sleep.eu/
